Cystic Fibrosis Therapy: A Community Ecology Perspective
Authors:
- 1 February 2013
- journal article
- review article
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 48 (2) , 150-156
Abstract
Current therapy for cystic fibrosis (CF) focuses on minimizing the microbial community and the host’s immune response through the aggressive use of airway clearance techniques, broad-spectrum antibiotics, and treatments that break down the pervasive endobronchial biofilm. Antibiotic selection is typically based on the susceptibility of individual microbial strains to specific antibiotics in vitro. Often this approach cannot accurately predict medical outcomes because of factors both technical and biological. Recent culture-independent assessments of the airway microbial and viral communities demonstrated that the CF airway infection is considerably more complex and dynamic than previously appreciated. Understanding the ecological and evolutionary pressures that shape these communities is critically important for the optimal use of current therapies (in both the choice of therapy and timing of administration) and the development of newer strategies. The climax–attack model (CAM) presented here, grounded in basic ecological principles, postulates the existence of two major functional communities. The attack community consists of transient viral and microbial populations that induce strong innate immune responses. The resultant intense immune response creates microenvironments that facilitate the establishment of a climax community that is slower-growing and inherently resistant to antibiotic therapy. Newer methodologies, including sequence-based metagenomic analysis, can track not only the taxonomic composition but also the metabolic capabilities of these changing viral and microbial communities over time. Collecting this information for CF airways will enable the mathematical modeling of microbial community dynamics during disease progression. The resultant understanding of airway communities and their effects on lung physiology will facilitate the optimization of CF therapies.Keywords
This publication has 55 references indexed in Scilit:
- Decade-long bacterial community dynamics in cystic fibrosis airwaysProceedings of the National Academy of Sciences, 2012
- Enhancing the utility of existing antibiotics by targeting bacterial behaviour?British Journal of Pharmacology, 2012
- Spatial distribution of microbial communities in the cystic fibrosis lungThe ISME Journal, 2011
- Evolutionary dynamics of bacteria in a human host environmentProceedings of the National Academy of Sciences, 2011
- Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communitiesThe ISME Journal, 2010
- Efficacy of Bacteriophage Therapy in a Model ofBurkholderia cenocepaciaPulmonary InfectionThe Journal of Infectious Diseases, 2010
- Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosisProceedings of the National Academy of Sciences of the United States of America, 2007
- Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosaProceedings of the National Academy of Sciences of the United States of America, 2006
- Evolving stealth: Genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infectionsProceedings of the National Academy of Sciences, 2006
- Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patientsProceedings of the National Academy of Sciences, 2006